Trials / Completed
CompletedNCT04679272
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.
Conditions
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-01-30
- Completion
- 2021-02-01
- First posted
- 2020-12-22
- Last updated
- 2021-03-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04679272. Inclusion in this directory is not an endorsement.